NORTH CHICAGO, Ill.,
May 26, 2021 /PRNewswire/ -- AbbVie
(NYSE: ABBV) will participate in Bernstein's 37th Annual
Strategic Decisions Conference on Wednesday,
June 2, 2021. Michael
Severino, M.D., vice chairman and president, and
Robert A. Michael, executive vice
president and chief financial officer, will present virtually at
2:30 p.m. Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, women's health and
gastroenterology, in addition to products and services across its
Allergan Aesthetics portfolio. For more information about AbbVie,
please visit us at www.abbvie.com. Follow @abbvie on
Twitter, Facebook, Instagram, YouTube and LinkedIn.
View original
content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-bernsteins-37th-annual-strategic-decisions-conference-301299171.html
SOURCE AbbVie